David L. Lacey

Insider Reports History

Location
Brisbane, CA
Signature
/s/ Carolyn Tang, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David L. Lacey:

Company Role Class Num Shares Value Price $ Report Date Ownership
Arcus Biosciences, Inc. Director Common Stock 70,952 $576,130 $8.12 10 Jun 2025 Direct
Arcus Biosciences, Inc. Director Stock Option (Right to Buy) 38,300 10 Jun 2025 Direct
Nurix Therapeutics, Inc. Director Director Stock Option (right to buy) 25,000 19 May 2025 Direct
Atreca, Inc. Director Stock Option (right to buy) 12,000 13 Jun 2023 Direct

Insider Reports Filed by David L. Lacey

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RCUS Arcus Biosciences, Inc. 10 Jun 2025 2 $0 4 Director 12 Jun 2025, 16:28
NRIX Nurix Therapeutics, Inc. 19 May 2025 1 $0 4 Director 19 May 2025, 17:33
RCUS Arcus Biosciences, Inc. 23 Jan 2025 1 $0 4 Director 27 Jan 2025, 16:30
RCUS Arcus Biosciences, Inc. 06 Jun 2024 2 $0 4 Director 07 Jun 2024, 18:20
NRIX Nurix Therapeutics, Inc. 20 May 2024 1 $0 4 Director 20 May 2024, 19:25
RCUS Arcus Biosciences, Inc. 15 Jun 2023 2 $0 4 Director 16 Jun 2023, 20:08
/report/000120919123037518-lacey-david-l-2023-06-13 Atreca, Inc. 13 Jun 2023 1 $0 4 Director 15 Jun 2023, 18:07
NRIX Nurix Therapeutics, Inc. 04 May 2023 1 $0 4 Director 04 May 2023, 19:57
RCUS Arcus Biosciences, Inc. 14 Jun 2022 2 $0 4 Director 16 Jun 2022, 16:23
/report/000120919122036105-lacey-david-l-2022-06-08 Atreca, Inc. 08 Jun 2022 1 $0 4 Director 10 Jun 2022, 18:45
NRIX Nurix Therapeutics, Inc. 05 May 2022 1 $0 4 Director 06 May 2022, 17:40
/report/000120919121039845-lacey-david-l-2021-06-09 Atreca, Inc. 09 Jun 2021 1 $0 4 Director 11 Jun 2021, 16:33
RCUS Arcus Biosciences, Inc. 03 Jun 2021 2 $0 4 Director 07 Jun 2021, 16:38
NRIX Nurix Therapeutics, Inc. 06 May 2021 1 $0 4 Director 24 May 2021, 19:49